InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: rocky301 post# 48894

Wednesday, 01/09/2013 8:50:29 AM

Wednesday, January 09, 2013 8:50:29 AM

Post# of 92948
Yes and that is good. However until the FDA grants such a request the current Phase 1/2 trial continues as is with the no better than 20/400 inclusivity criteria for patients to be selected for the 150K and 200K Cohorts.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.